Research-driven analysis for PE firms, corporate development teams, and strategy functions evaluating markets, targets, and competitive position. Rigorous work. Straight answers.
The research behind high-stakes decisions is either overpriced, too slow, or too shallow. The major firms deliver rigor, but at outdated price points and timelines. Independent analysts are faster and cheaper, but rarely produce defensible work. The space between the two is where most buyers actually need to operate: rigorous analysis, practical timelines, economics that make sense for the decision at hand.
A structured analytical process built for depth and speed. Institutional-quality output without the staffing model, timeline, or cost structure of a traditional engagement.
Full-scope research and analysis in days to weeks, not months. Traceable sourcing. Defensible conclusions.
Pre-built research products available for immediate purchase. Industry reports, competitive snapshots, and battlecard sets. $300–$3,000.
Industry Intelligence Reports · Competitive Landscape Snapshots · Sales Battlecard Sets · Refreshed Data Products
Select from a defined menu, specify your inputs. Brief intake call, structured deliverable, 1–2 revision rounds. $2,000–$10,000.
Custom Competitive Landscape Assessments · Market Sizing & Opportunity Assessments · Competitor Deep Dives · Industry Entry Briefings · Regulatory & Compliance Landscapes
Fully scoped engagements with iterative collaboration. Custom requirements, pricing, and timeline. $8,000–$25,000+.
Commercial Due Diligence · Go-to-Market Strategy Research · Ongoing Competitive Intelligence Programs · Growth Strategy · Value Creation Plans
Add-ons available for made-to-order research: primary research, ongoing monitoring, client data integration.
I spent ten years in PE-backed consulting and operating roles: buy-side and sell-side diligence, operational improvement, transformation programs, M&A integration, and the analytical frameworks behind investment decisions. Advisory work at Alvarez & Marsal and The Keystone Group. Operating roles at two PE-backed portfolio companies across specialty medical and nuclear safety, leading strategic projects spanning the United States and Europe.
That experience is now packaged into an independent practice with a structured methodology and low overhead. The result is work with the rigor of a top-tier engagement at a fraction of the cost and timeline.
Whether you need a quick competitive snapshot or a full due diligence workstream, the first step is the same.